Bacopa monnieri vs Noopept
Side-by-side comparison of Bacopa monnieri and Noopept: mechanism, half-life, dose range, safety profile, and vendor pricing.
Price snapshot
Bacopa monnieri
Noopept
Bacopa monnieri
Bacopa monnieri is a creeping, succulent-leaved aquatic perennial that grows in wetlands, bogs, and rice paddies across the Indian subcontinent, Southeast Asia, northern Australia, and the southern United States. Known…
No vendor price on file.
Full Bacopa monnieri profileNoopept
Noopept is the common brand and research name for N-phenylacetyl-L-prolylglycine ethyl ester (GVS-111; INN omberacetam), a small dipeptide nootropic developed in the 1990s at the Russian Academy of Medical Sciences'…
Lowest listed price: $49.99 across 1 listing
Full Noopept profileSide-by-side comparison
| Attribute | Bacopa monnieri | Noopept |
|---|---|---|
| Category | Nootropic Adaptogen | Nootropics |
| Research Stage | Preclinical | Preclinical |
| Mechanism of Action | Bacopa monnieri's cognitive effects emerge from at least six convergent molecular mechanisms that span neurotransmitter modulation, trophic-factor expression, structural plasticity, antioxidant defense, vascular regulation, and receptor-level anxiolysis. No… | Noopept's mechanism of action is multifaceted and — despite decades of research — incompletely understood. Several convergent pathways have been proposed, each supported by preclinical data but none definitively established as the primary driver of its… |
| Half-Life | — | — |
| Typical Dose Range | — | — |
| Dosing Frequency | — | — |
| Administration | — | — |
| Side Effects | Bacopa monnieri's side-effect profile is dominated by gastrointestinal symptoms, which occur in 20-30% of users at therapeutic doses and represent the primary reason users discontinue the compound. Mechanistically, the GI effects appear to reflect Bacopa's… | Noopept is generally well tolerated in the Russian clinical literature, with side effects that are typically mild and transient. However, "well tolerated in Russian open-label trials" is a weaker safety claim than the rigorous multi-phase trial data underlying… |
| Molecular Weight | — | 318.37 g/mol |
| Common Vial Sizes | — | — |
Price History
2 data pointsBacopa monnieri: potential benefits
- No structured benefit list published.
Noopept: potential benefits
- Memory enhancement
- BDNF/NGF upregulation
- Neuroprotection
- Focus and learning speed
- Anxiety reduction (moderate)
- Anti-amyloid properties
Frequently asked
What's the difference between Bacopa monnieri and Noopept?
Bacopa monnieri is a nootropic adaptogen that bacopa monnieri's cognitive effects emerge from at least six convergent molecular mechanisms that span neurotransmitter modulation, trophic-factor expression, structural…. Noopept is a nootropics that noopept's mechanism of action is multifaceted and — despite decades of research — incompletely understood. several convergent pathways have been proposed, each supported by…. The two differ in mechanism, half-life (not reported vs not reported), and typical dose range.
Which has the longer half-life, Bacopa monnieri or Noopept?
Bacopa monnieri has a half-life of not reported. Noopept has a half-life of not reported. Longer half-lives generally mean less frequent dosing but slower on/off kinetics.
Can you stack Bacopa monnieri and Noopept?
Stacking depends on mechanism overlap, safety profile, and goals. Bacopa monnieri and Noopept should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds.
See current vendor prices
Listings from the vendors we track. Prices change often, so check the vendor before you buy.
Before you buy Bacopa monnieri or Noopept
Check the vendor trust score. Every supplier we track is rated 0-100 on COA verification, payment transparency, shipping, reviews, and listings: one published, reproducible methodology, applied to every vendor.
Related comparisons
Research use only. BodyHackGuide is a research and price-comparison reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. Every vendor is ranked on the same public, reproducible methodology. See editorial standards and affiliate disclosure.